-
Oct 24, 2024 | 
jdsupra.com | Alexandra Shalom |Roger D. Strode |Adria Warren
Although private equity (PE) sponsors have been active investors in the health care services industry for the last decade, PE-backed health care providers today constitute only 4% of the United States health market by revenue. Moreover, growth in PE investment in health care has slowed over the past six years.
-
Oct 8, 2024 | 
mondaq.com | Lawrence W. Vernaglia |Adria Warren
Turbocharged during the COVID-19 pandemic, evolving technology,
enhanced reimbursement modalities and increased regulatory
flexibility are creating new opportunities to offer acute-level
oncology care to patients in their own homes. For hospitals and
providers looking to expand their programs into the home and
reimagine patient care, these are the key legal and regulatory
things to know in September 2024.
-
Oct 8, 2024 | 
jdsupra.com | Lawrence W. Vernaglia |Adria Warren
Turbocharged during the COVID-19 pandemic, evolving technology, enhanced reimbursement modalities and increased regulatory flexibility are creating new opportunities to offer acute-level oncology care to patients in their own homes. For hospitals and providers looking to expand their programs into the home and reimagine patient care, these are the key legal and regulatory things to know in September 2024.
-
Sep 25, 2024 | 
mondaq.com | Nathan Beaver |Aaron Maguregui |Rachel Goodman |Adria Warren
Artificial intelligence (AI) has the power to revolutionize
health care. In oncology, there are now opportunities to apply AI
to support diagnostics, predictive analytics, and administrative
functions.
This hot topic was discussed in sessions on Digital Innovation
(a cancer-specific AI use case) and Advanced Clinical Pathways at
the September 2024 Cancer Care Business Exchange.
-
Sep 18, 2024 | 
jdsupra.com | Anil Shankar |Adria Warren
The 340B Drug Pricing Program continues to provide critical support for covered entities, although the program is subject to ongoing scrutiny and congressional, judicial, and industry pressures. Certain key guidance documents issued by the Health Resources and Services Administration (HRSA) were recently rejected by the courts, and additional cases are pending. Congress may ultimately decide the direction of the program.
-
Aug 7, 2024 | 
mondaq.com | Alexandra Shalom |Adria Warren |Lawrence W. Vernaglia |Ilana Meyer
The Massachusetts legislative session officially closed on
August 1, 2024 after an unusual half day extension. The
193rd legislative session left many omnibus bills
unpassed, including S.B. 2881, "an Act enhancing the market
review process" (Act). The proposed Act includes many
provisions aimed at strengthening regulatory oversight. It could
also have significant implications for health management services
organizations, including many private equity-backed platforms and
telehealth companies.
-
Jun 5, 2024 | 
pharmaceuticalcommerce.com | Anil Shankar |Adria Warren |Jordan Smiley
June 5, 2024The courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty. The 340B Drug Pricing Program continued to evolve in 2023, and further changes may be forthcoming as a result of ongoing lawsuits and regulatory action.
-
Dec 15, 2023 | 
mondaq.com | Jarrod Brodsky |Daniel Costandy |Judith A. Waltz |Adria Warren
On December 7, 2023, the Senate Budget Committee (the
"Committee") launched a bipartisan
investigation into the reality of private equity ownership of
hospitals in the United States. This investigation stems from
concerns around negative patient outcomes associated with hospitals
under private equity ownership, and key committee members have sent
letters to the CEOs of major private equity firms outlining the
Committee's concerns about how these entities own and operate
hospitals.
-
Dec 13, 2023 | 
jdsupra.com | Daniel Costandy |Judith A. Waltz |Adria Warren
On December 7, 2023, the Senate Budget Committee (the “Committee”) launched a bipartisan investigation into the reality of private equity ownership of hospitals in the United States. This investigation stems from concerns around negative patient outcomes associated with hospitals under private equity ownership, and key committee members have sent letters to the CEOs of major private equity firms outlining the Committee’s concerns about how these entities own and operate hospitals.
-
Dec 13, 2023 | 
mondaq.com | Benjamin Dryden |Adria Warren
On December 7, 2023, the Biden Administration
announced several new initiatives intended to "promote
competition" in the health care sector. These initiatives
reflect a broad range of concerns about rising costs in health
care, including pointed references to "price gouging" and
"profiteering" by private equity and big business.
